1009463--3/16/2010--GLOBAL_MED_TECHNOLOGIES

related topics

{operation, international, foreign}

{customer, product, revenue}

{stock, price, share}

{product, market, service}

{product, liability, claim}

{stock, price, operating}

{personnel, key, retain}

{operation, natural, condition}

{product, candidate, development}

{acquisition, growth, future}

{interest, director, officer}

{property, intellectual, protect}

{cost, operation, labor}

{condition, economic, financial}

A purported stockholder class action lawsuit has been filed against Global Med, Haemonetics, Acquisition Sub and members of our Board of Directors and certain officers challenging the Merger Agreement and seeking a temporary restraining order to enjoin the Offer. Risks Related to Our Business Our reported revenue and operating results may fluctuate widely due to irregular sales cycles, contract terms and the application of accounting rules. We are dependent on major channel partners to sell our products into certain markets. We may not be able to realize our sales backlog as expected which could reduce our revenue and operating results. Our recurring maintenance revenue could be reduced if we fail to meet service requirements. Our results are vulnerable to general economic conditions. Our cash flows from operations may fluctuate widely from quarter to quarter and our revenue and cash receipts may not be sufficient to meet the operating needs of our business. If we are unable to successfully integrate the operations of Inlog and eDonor, our revenue and results of operations could be adversely affected. Our business and our software products are subject to substantial competition which may adversely affect our ability to attract and retain customers. Our revenue may be dependent on our ability to update and enhance our existing products and services and to develop new ones. We cannot be certain that our research and development activities will be successful. We depend significantly upon our intellectual property rights and the failure to protect our rights could reduce our revenue and/or increase our operating costs. Failure to comply with government regulations and requirements could preclude us from continuing to market our existing products or introducing new products which could adversely affect our revenue and results of operations. We may be subject to product liability exposure. We may pursue strategic acquisitions and if we are unable to successfully acquire or integrate these companies, we may not be able to grow our revenue. We depend on our key personnel for the success of our business and the loss of one or more key personnel could have an adverse effect on our ability to manage our business. Risks Related to International Operations We face a number of risks associated with international operations We are subject to foreign exchange risks Risks Related to Our Stock If Penny Stock regulations impose restrictions on the marketability of our common stock, the abilty of our shareholders to sell shares of our stock could be impaired. Our common stockholders could face substantial potential dilution from our Series A Convertible Preferred Stock and outstanding stock options, warrants, unvested restricted stock and contingently issuable shares

Full 10-K form ▸

1009463--3/16/2010--GLOBAL_MED_TECHNOLOGIES_INC